| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |